Navigation Links
Scientists discover a genetic switch that links animal growth and cancer

Laboratory discoveries by scientists at two universities may lead to new directions in cancer therapy drugs. The researchers have discovered that a genetic switch involved in growth and development of an animal is the same one used to prevent normal cells from becoming cancerous.

The findings are reported in the April 18 issue of Current Biology. Experiments were carried out by first author Masamitsu Fukuyama, a postdoctoral scientist working in the laboratories of Joel H. Rothman, a professor in the Department of Molecular, Cellular and Developmental Biology at the University of California, Santa Barbara, and Ann Rougvie, a professor in the Department of Genetics, Cell Biology, and Development at the University of Minnesota. Fukuyama is now an assistant professor at the University of Tokyo.

"The parallels between the control of development during the normal process of maturation and the control of cancer growth are striking," said Rothman. "We recognize that cancer cells in many ways simply mimic what normal cells do in a developing animal, only at an unfortunate time and place."

In life, there is a time to wait and a time to grow, Rothman explained. "Many creatures remain in a waiting state until conditions are right for growth. A tiny redwood, for example, can remain persistently arrested for years inside a seed. Only when the seed senses water will it sprout and initiate development into a mature tree. Many animals similarly halt their development until the environment is right for growth and development."

The process is the same with cells, the basic units of life. Many cells remain in a quiescent state, neither growing nor multiplying until they are triggered to do so by an environmental cue, such as a hormone or injury. Cells possess braking mechanisms that keep them in this quiescent state. When the brakes fail, cells that should be static start growing and dividing, leading to cancer. These brakes are proteins called tumor sup
'"/>

Source:University of California - Santa Barbara


Page: 1 2

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding

Post Your Comments:
(Date:11/25/2009)...ital to your health as what you eat, found researc... Their experiments in mice revealed that the daily...verthe body,s metabolic clearinghouseis mostly con...dian clock as conventional wisdom had it. , "If...umber of genes completely independent of the circa...
(Date:11/24/2009)...es from collapsing have been true life-savers. But...ed -- once the arteries are strengthened, they bec... but to leave them in place. , Prof. Meital Zilb...dical Engineering has developed a new patent-pendi... needed, then dissolves. , "Our new composite fi...
(Date:11/24/2009)...debate. A high-profile study a few years ago sugge...on from trees and leaves, evidence for a very clos...ems. , But new research from the University of W...ae provide a much richer diet for fish and other a...week in the Proceedings of the National Academy o...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 1Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 2Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 3Go to the doctor 3F Only if Im really sick 52314 1Go to the doctor 3F Only if Im really sick 52314 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 1Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 3
...ngs about the causes of mad cow disease show that ...also in the genes of cattle," said Juergen A. Rich...edicine and Pathobiology at Kansas State Universit...al years ago, Richt said, it was thought that the ...thy -- also called BSE or mad cow disease -- was a...
...Stevens Institute of Technology has been awarded a...e project, "MRI: Acquisition of an Inductively Cou...abrication." The Stevens team includes Yong Shi, t...gineering department; Stefan Strauf, a Professor t...e Professor in the Mechanical Engineering departme...
...t Service Southern Research Station (SRS) today an...t Disturbances: Wildfires, Storms, and Invasive Sp...ffers a synthesis of new approaches to understandi...s. , The Economics of Forest Disturbances is th...e framework for analyzing the economic effects of ...
Other Biology News:K-State professor's USDA research shows mad cow disease also caused by genetic mutation 2NSF awards two grants to Stevens for nano/micro device fabrication and nano sensor development 2Book breaks new ground in the study of economics and forest threats management 2
(Date:11/24/2009)..., , REDWOOD CITY, Calif., Nov. 24 /PRNe... GHDX ) today announced that Randy Scott, Genomic...21st Annual Piper Jaffray Health Care Conference i...:00 a.m. ET. ,, To access the live and subsequ...the Investor Relations section of Genomic Health,s...
(Date:11/24/2009)..., Program Connects Custom... Samples Collected with DNA Genotek Products , ...24, 2009 -- DNA Genotek , a leading provider of p...ation and preparation, today announced its new glo...t enhancements for DNA Genotek,s partner community...
(Date:11/24/2009)..., , SEATTLE, Nov. 24 /PRNewswire-Firs...d MTA: CTIC) management will present at the 21st A...nference will be held December 1-2, 2009, at the N...Tuesday, December 1 at 11:00 a.m. Eastern Time in ...s presentation will be available at www.cellthera...
(Date:11/23/2009)..., CHAMPAIGN, Ill. You can think of it as origami...iversity of Illinois have developed a technique fo...e silicon structures from thin films by coupling p...by capillary interactions. , The films, only a fe... is not possible with thicker pieces of the same m...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
... 12 Anthera Pharmaceuticals, Inc., a,privately he...mmatory drugs,announced today that it has complete...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib (A-0...of an Acute,Coronary Syndrome (ACS) event. , "...
... Pharmasset, Inc. (Nasdaq: VRUS ) announced toda...have agreed with the FDA on the final design for a... of hepatitis C (HCV), slated to initiate in the f...at R7128 is advancing into a large phase 2b trial,...ief Medical Officer. "R7128 is the most advanced n...
...nuary 12 , - Reflects Strong International Gr...ding IP Management Specialist and Legal Support Se...llectual property,( http://www.cpaglobal.com ) (IP...outsourced legal support services, has today marke...ew brand worldwide. , Founded in 1969 as a spe...
Other Biology Technology:Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 2Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 2Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 4Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 5CPA Global Marks 40th Anniversary With Launch of New Brand 2CPA Global Marks 40th Anniversary With Launch of New Brand 3
GIBCO Fetal Bovine Serum Heat-Inactivated from Invitrogen
Mouse Anti-EGFr VIII Antibody, Unconjugated from Invitrogen
Custom siRNA, PAGE purified from Ambion
GIBCO Kanamycin Sulfate from Invitrogen
Biology Products: